News

Drug industry anxious about scrapping price regulation scheme

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39526.738345.DB (Published 27 March 2008) Cite this as: BMJ 2008;336:686
  1. Andrew Cole
  1. 1London

    Almost half (46%) of the United Kingdom’s drug companies expect to cut back on clinical trials in the coming year because of continued uncertainty about future arrangements for pricing drugs.

    In a survey of more than 100 companies earlier this month on behalf of the Association of the British Pharmaceutical Industry and the Confederation of British Industry three quarters said they had little confidence in the current UK market environment, and 83% expected things to get worse in the next year.

    The survey also showed that 30% of drug companies expect to cut staff in the next year, and more than …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe